Since 2017, The Biocodex Microbiota Foundation rewards international research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by a committee of independent international scientists.
Through this grant, the Foundation aims to support Physicians, PhDs and Pharm D working in subject areas, such as gastroenterology, paediatrics, microbiology, infectious diseases and internal medicine and based anywhere in the world.
This year, the International Scientific Committee has chosen the following topic: "new metabolites and small molecules, or novel functions of previously described metabolites, from gut microbiota that have an impact on gut mucosal pathways relevant to human health and disease. Already well-known metabolites such as SCFA, bile acids, tryptophan-derived molecules, virulence factors including toxins and large molecules are excluded from this call unless they are involved in novel functions that have not been previously described". You can apply either with a clinical or fundamental research proposals. Our scientific committee will select the best project among all the submitted ones.
Next
The international scientific committee of the Biocodex Microbiota Foundation awarded Søren Johannes Sørensen Professor, Ph.D. for his study project: “Linking the early life resistome and microbiome maturation”.
The international scientific committee of the Biocodex Microbiota Foundation awarded Pr Richard DELORME for his study project: “Randomized controlled trial evaluating the effect of transplantation of fecal microbiota in children with autism spectrum disorders and gastrointestinal symptoms”.
For this edition, the scientific committee awarded Pr Premysl BERCIK for his study of the mechanisms and treatments of clostridium difficile-induced post-infectious Irritable Bowel Syndrom.
For this edition, the scientific committee awarded Prof. Emily Balskus for her research on inhibiting the gut microbiota's degradation of Parkinson's disease medication.
For this edition, the scientific committee awarded Bernd Schnabl, MD, a professor from University of California for his research on the correlation between gut microbiota and alcoholic hepatitis.